These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18700242)

  • 1. By the way, doctor. Celebrex and bleeding.
    Komaroff A
    Harv Health Lett; 2008 May; 33(7):8. PubMed ID: 18700242
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolonged cholestasis associated with short-term use of celecoxib.
    Chamouard P; Walter P; Baumann R; Poupon R
    Gastroenterol Clin Biol; 2005 Dec; 29(12):1286-8. PubMed ID: 16518289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit versus risk in the use of non-selective NSAIDs and selective COX-2 inhibitors.
    Aalbers J
    Cardiovasc J Afr; 2012 Jul; 23(6):356. PubMed ID: 23091830
    [No Abstract]   [Full Text] [Related]  

  • 4. Celecoxib-induced upper gastrointestinal hemorrhage and ulceration.
    Crawford AS; White JG
    South Med J; 2002 Dec; 95(12):1444-6. PubMed ID: 12597315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gastroduodenal tolerance of celecoxib (celebrex) in patients with osteoarthrosis: an endoscopic evaluation].
    Karateev AE
    Ter Arkh; 2001; 73(5):63-4. PubMed ID: 11517755
    [No Abstract]   [Full Text] [Related]  

  • 6. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial.
    Chan FK; Lanas A; Scheiman J; Berger MF; Nguyen H; Goldstein JL
    Lancet; 2010 Jul; 376(9736):173-9. PubMed ID: 20638563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pfizer: Celebrex increases heart attack risk.
    Health News; 2005 Feb; 11(2):2. PubMed ID: 15732142
    [No Abstract]   [Full Text] [Related]  

  • 8. [Celecoxib induced toxiderma with positive patch-test].
    Verbeiren S; Morant C; Charlanne H; Ajebbar K; Caron J; Modiano P
    Ann Dermatol Venereol; 2002 Feb; 129(2):203-5. PubMed ID: 11937958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute colitis closely following the beginning of celecoxib treatment].
    Houmani Z; Imbert A; Duchmann JC; Messerschmitt C; Barbare JC; Latrive JP; Biour M
    Gastroenterol Clin Biol; 2005 Dec; 29(12):1294-5. PubMed ID: 16518292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Toxic epidermal necrolysis and celecoxib (Celebrex)].
    Schmutz JL; Barbaud A; Trechot P
    Ann Dermatol Venereol; 2004 Jan; 131(1 Pt 1):107. PubMed ID: 15041861
    [No Abstract]   [Full Text] [Related]  

  • 11. 12 things you should know about pain relievers. A dozen take-home messages about the pills that take the hurt away.
    Harv Health Lett; 2007 Feb; 32(4):4-5. PubMed ID: 17328139
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypersensitivity to celecoxib].
    Fradet G; Robin-Le Nechet A; Huguenin H; Chiffoleau A
    Ann Med Interne (Paris); 2003 May; 154(3):181-2. PubMed ID: 12910047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials.
    White WB; West CR; Borer JS; Gorelick PB; Lavange L; Pan SX; Weiner E; Verburg KM
    Am J Cardiol; 2007 Jan; 99(1):91-8. PubMed ID: 17196469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib (Celebrex): 1 year later.
    McMorran M; Morawiecka I
    CMAJ; 2000 Apr; 162(7):1044-6, 1048-50. PubMed ID: 10763409
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclooxygenase inhibitors and cardiovascular risk.
    Andersohn F; Suissa S; Garbe E
    JAMA; 2007 Feb; 297(6):586-7; author reply 587-8. PubMed ID: 17299191
    [No Abstract]   [Full Text] [Related]  

  • 16. Celecoxib and CVS risk--lessons from the APC and PreSAP studies.
    Armstrong DJ
    Rheumatology (Oxford); 2007 Apr; 46(4):561-2. PubMed ID: 17132690
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous reaction to oral celecoxib with positive patch test.
    Alonso JC; Ortega JD; Gonzalo MJ
    Contact Dermatitis; 2004 Jan; 50(1):48-9. PubMed ID: 15059110
    [No Abstract]   [Full Text] [Related]  

  • 18. [Nephrotic syndrome associated to celecoxib].
    Sirvent AE; Enríquez R; Amorós F; Reyes A
    Nefrologia; 2005; 25(1):81-2. PubMed ID: 15789542
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
    Huang WF; Hsiao FY; Wen YW; Tsai YW
    Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib in the treatment of haemophilic synovitis, target joints, and pain in adults and children with haemophilia.
    Rattray B; Nugent DJ; Young G
    Haemophilia; 2006 Sep; 12(5):514-7. PubMed ID: 16919082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.